Expanding hemophilia care in developing countries

Area of Science:

• Global Health
• Hematology
• Rare Diseases

Background:

• Hemophilia affects numerous individuals worldwide, with a significant majority lacking diagnosis and treatment.
• A substantial disparity exists in hemophilia care and factor concentrate availability between developed and developing countries.
• Limited access to diagnostics, understanding of the disorder, and blood banking facilities contribute to inadequate patient care.

Purpose of the Study:

• To highlight the global disparities in hemophilia diagnosis and treatment.
• To identify key barriers to effective hemophilia care in developing countries.
• To present the World Federation of Haemophilia's (WFH) initiatives to improve hemophilia management.

Main Methods:

• Review of global hemophilia statistics and care standards.
• Analysis of factors contributing to underdiagnosis and undertreatment.
• Description of WFH programs and educational strategies.

Main Results:

• Approximately 70% of hemophilia patients are underdiagnosed and untreated, predominantly in developing countries.
• Life expectancy for hemophiliacs in developing nations is significantly lower than in developed countries.
• Progress has been made in organizing hemophilia care in several developing countries.

Conclusions:

• Addressing the underdiagnosis and undertreatment of hemophilia requires targeted global health interventions.
• Enhancing diagnostic capabilities, healthcare provider education, and factor concentrate supply are crucial.
• Collaborative efforts, including governmental support, are essential for improving hemophilia care worldwide.